$GPRE
Green Plains Inc. Stock $gpre

$gpre Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000130940224000092 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$618.8M	$597.2M
YoY Change	-27.84%	-28.3%
Cost Of Revenue	$581.0M	$588.8M
YoY Change	-30.43%	-28.63%
Gross Profit	$37.82M	$8.367M
YoY Change	67.8%	5.32%
Gross Profit Margin	6.11%	1.4%
Selling, General & Admin	$33.95M	$31.77M
YoY Change	-15.95%	-0.24%
% of Gross Profit	89.76%	379.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$21.58M	$21.49M
YoY Change	-12.35%	-15.36%
% of Gross Profit	57.07%	256.81%
Operating Expenses	$33.95M	$31.77M
YoY Change	-47.79%	-0.24%
Operating Profit	-$17.71M	-$44.89M
YoY Change	-58.31%	-20.61%
Interest Expense	-$6.004M	$7.786M
YoY Change	-13.86%	-20.05%
% of Operating Profit
Other Income/Expense, Net	-$5.659M	-$4.827M
YoY Change	3414.91%	-24.39%
Pretax Income	-$23.37M	-$49.72M
YoY Change	-52.89%	-20.99%
Income Tax	-$300.0K	$300.0K
% Of Pretax Income
Net Earnings	-$24.35M	-$51.41M
YoY Change	-53.71%	-26.89%
Net Earnings / Revenue	-3.93%	-8.61%
Basic Earnings Per Share	-$0.38	-$0.81
Diluted Earnings Per Share	-$0.38	-$0.81
COMMON SHARES
Basic Shares Outstanding	64.62M shares	64.26M shares
Diluted Shares Outstanding	63.93M shares	63.34M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$195.6M	$237.3M
YoY Change	-37.49%	-33.0%
Cash & Equivalents	$195.6M	$237.3M
Short-Term Investments
Other Short-Term Assets	$68.14M	$71.72M
YoY Change	-39.25%	-19.71%
Inventory	$188.0M	$191.1M
Prepaid Expenses
Receivables	$99.07M	$87.56M
Other Receivables	$1.072M	$716.0K
Total Short-Term Assets	$551.8M	$588.4M
YoY Change	-32.4%	-29.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.019B	$1.022B
YoY Change	-8.16%	-0.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$48.50M
YoY Change
Other Assets	$119.3M	$113.7M
YoY Change	23.56%	24.38%
Total Long-Term Assets	$1.212B	$1.211B
YoY Change	0.44%	0.56%
TOTAL ASSETS
Total Short-Term Assets	$551.8M	$588.4M
Total Long-Term Assets	$1.212B	$1.211B
Total Assets	$1.764B	$1.799B
YoY Change	-12.81%	-11.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$109.3M	$123.6M
YoY Change	4.03%	-3.88%
Accrued Expenses	$52.08M	$50.35M
YoY Change	-30.3%	6.53%
Deferred Revenue
YoY Change
Short-Term Debt	$124.6M	$130.0M
YoY Change	-49.59%	-38.85%
Long-Term Debt Due	$1.830M	$1.828M
YoY Change	-0.27%	-0.22%
Total Short-Term Liabilities	$328.5M	$336.4M
YoY Change	-36.07%	-29.75%
LONG-TERM LIABILITIES
Long-Term Debt	$483.8M	$490.3M
YoY Change	-1.99%	-0.97%
Other Long-Term Liabilities	$18.43M	$18.15M
YoY Change	-79.43%	-22.56%
Total Long-Term Liabilities	$502.2M	$508.4M
YoY Change	-13.88%	-1.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$328.5M	$336.4M
Total Long-Term Liabilities	$502.2M	$508.4M
Total Liabilities	$882.7M	$899.0M
YoY Change	-29.09%	-15.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$311.6M	-$287.2M
YoY Change	17.42%	35.01%
Common Stock	$67.00K	$67.00K
YoY Change	8.06%	8.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$867.4M	$887.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.764B	$1.799B
YoY Change	-12.81%	-11.57%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$24.35M	-$51.41M
YoY Change	-53.71%	-26.89%
Depreciation, Depletion And Amortization	$21.58M	$21.49M
YoY Change	-12.35%	-15.36%
Cash From Operating Activities	-$15.12M	-$50.60M
YoY Change	-70.62%	-56.74%
INVESTING ACTIVITIES
Capital Expenditures	$17.69M	$21.80M
YoY Change	8.45%	-33.13%
Acquisitions
YoY Change
Other Investing Activities	-$7.615M	-$8.408M
YoY Change	29.79%	197.21%
Cash From Investing Activities	-$25.30M	-$30.20M
YoY Change	14.1%	-14.73%
FINANCING ACTIVITIES
Cash Dividend Paid		$0.00
YoY Change		-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.87M	-$20.58M
YoY Change	-147.31%	-134.04%
NET CHANGE
Cash From Operating Activities	-15.12M	-$50.60M
Cash From Investing Activities	-25.30M	-$30.20M
Cash From Financing Activities	-11.87M	-$20.58M
Net Change In Cash	-52.29M	-$101.4M
YoY Change	7.68%	10.28%
FREE CASH FLOW
Cash From Operating Activities	-$15.12M	-$50.60M
Capital Expenditures	$17.69M	$21.80M
Free Cash Flow	-$32.81M	-$72.39M
YoY Change	-51.59%	-51.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-66249000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2805059	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	31174000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	843733000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	146323000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	990056000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1939322000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	588847000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31769000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31845000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21487000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25386000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	642103000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	889489000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-44889000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-56540000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2510000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3165000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	7786000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9738000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	449000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	189000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4827000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6384000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-49716000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-62924000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	329000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3429000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1077000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	104000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-51122000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-66249000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	290000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4075000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-51412000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-70324000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63341000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63341000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58549000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58549000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-51122000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-66249000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	1916000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	4023000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-6043000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-12788000	usd
CY2024Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-1682000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-535000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-5305000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1701000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-738000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11087000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51860000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-77336000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	290000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4075000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52150000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-81411000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21487000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25386000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	609000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	717000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	4202000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	233000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3491000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3053000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2828000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1077000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	104000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-858000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1625000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6890000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2064000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20459000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	757000	usd
CY2024Q1	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-7010000	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-10287000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	627000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3215000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-65787000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-94131000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	446000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	452000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-613000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-638000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50599000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-116968000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21795000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32591000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	8408000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2829000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30203000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35420000	usd
CY2024Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	2009000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	515000	usd
CY2024Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	181430000	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	359908000	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	157570000	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	285231000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	29196000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2024Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	5951000	usd
CY2023Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	5305000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4222000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8402000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3060000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20578000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60455000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-101380000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-91933000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	378762000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	500276000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	277382000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	408343000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	237302000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	354204000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	40080000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	54139000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	277382000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	408343000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-9000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-189000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	8888000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	10093000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5413000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5481000	usd
CY2024Q1	gpre	Issuance Of Common Stock Due To Merger IssuanceOfCommonStockDueToMerger	5000	usd
CY2023Q1	gpre	Issuance Of Common Stock Due To Merger IssuanceOfCommonStockDueToMerger	0	usd
CY2024Q1	gpre	Non Cash Extinguishment Of Non Controlling Interest Within Additional Paid In Capital NonCashExtinguishmentOfNonControllingInterestWithinAdditionalPaidInCapital	133765000	usd
CY2023Q1	gpre	Non Cash Extinguishment Of Non Controlling Interest Within Additional Paid In Capital NonCashExtinguishmentOfNonControllingInterestWithinAdditionalPaidInCapital	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates in the Preparation of Consolidated Fina</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ncial Statements</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The company bases its estimates on historical experience and assumptions it believes are proper and reasonable under the circumstances and regularly evaluates the appropriateness of its estimates and assumptions. Actual results could differ from those estimates. Certain accounting policies, including but not limited to those relating to derivative financial instruments and accounting for income taxes, are impacted significantly by judgments, assumptions and estimates used in the preparation of the consolidated financial statements.</span></div>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	48500000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	41700000	usd
CY2024Q1	gpre	Equity Method Investments Interest Capitalized EquityMethodInvestmentsInterestCapitalized	500000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41559000	usd
CY2024Q1	us-gaap	Derivative Excluded Component Gain Loss Recognized In Earnings DerivativeExcludedComponentGainLossRecognizedInEarnings	555655000	usd
CY2024Q1	us-gaap	Revenues Revenues	597214000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43047000	usd
CY2023Q1	us-gaap	Derivative Excluded Component Gain Loss Recognized In Earnings DerivativeExcludedComponentGainLossRecognizedInEarnings	789902000	usd
CY2023Q1	us-gaap	Revenues Revenues	832949000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	237302000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	40080000	usd
CY2024Q1	gpre	Inventories Carried At Market InventoriesCarriedAtMarket	25186000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	6955000	usd
CY2024Q1	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	8000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	309531000	usd
CY2024Q1	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	44504000	usd
CY2024Q1	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	3259000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	6642000	usd
CY2024Q1	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	903000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	55308000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	349574000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	29188000	usd
CY2023Q4	gpre	Inventories Carried At Market InventoriesCarriedAtMarket	45898000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	13311000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	437971000	usd
CY2023Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	54716000	usd
CY2023Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	9917000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	10577000	usd
CY2023Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	659000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	75869000	usd
CY2024Q1	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	44500000	usd
CY2023Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	54700000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	603800000	usd
CY2024Q1	gpre	Book Value Of Debt BookValueOfDebt	622200000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	585000000	usd
CY2023Q4	gpre	Book Value Of Debt BookValueOfDebt	599700000	usd
CY2024Q1	us-gaap	Accounts Receivable Fair Value Disclosure AccountsReceivableFairValueDisclosure	87600000	usd
CY2023Q4	us-gaap	Accounts Receivable Fair Value Disclosure AccountsReceivableFairValueDisclosure	94400000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q1	us-gaap	Revenues Revenues	597214000	usd
CY2023Q1	us-gaap	Revenues Revenues	832949000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	588847000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	832258000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	8367000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	691000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21487000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25386000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-44889000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-56540000	usd
CY2024Q1	gpre	Lower Of Cost Or Market Adjustment LowerOfCostOrMarketAdjustment	4200000	usd
CY2024Q1	us-gaap	Assets Assets	1799435000	usd
CY2023Q4	us-gaap	Assets Assets	1939322000	usd
CY2024Q1	gpre	Lower Of Cost Or Market Adjustment LowerOfCostOrMarketAdjustment	4200000	usd
CY2023Q4	gpre	Lower Of Cost Or Market Adjustment LowerOfCostOrMarketAdjustment	2600000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	70408000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73975000	usd
CY2024Q1	gpre	Inventory Grain Held For Sale InventoryGrainHeldForSale	25186000	usd
CY2023Q4	gpre	Inventory Grain Held For Sale InventoryGrainHeldForSale	45898000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	32950000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	32820000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	13169000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	14454000	usd
CY2024Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	49436000	usd
CY2023Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	48663000	usd
CY2024Q1	gpre	Inventories Carrying Amount InventoriesCarryingAmount	191149000	usd
CY2023Q4	gpre	Inventories Carrying Amount InventoriesCarryingAmount	215810000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3900000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	6963000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	13311000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	6647000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	10579000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-6987000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-2236000	usd
CY2024Q1	us-gaap	Hedged Asset Fair Value Hedge HedgedAssetFairValueHedge	25186000	usd
CY2024Q1	us-gaap	Hedged Asset Fair Value Hedge Cumulative Increase Decrease HedgedAssetFairValueHedgeCumulativeIncreaseDecrease	-3389000	usd
CY2023Q4	us-gaap	Hedged Asset Fair Value Hedge HedgedAssetFairValueHedge	45898000	usd
CY2023Q4	us-gaap	Hedged Asset Fair Value Hedge Cumulative Increase Decrease HedgedAssetFairValueHedgeCumulativeIncreaseDecrease	-1104000	usd
CY2024Q1	us-gaap	Trading Gains Losses TradingGainsLosses	1800000	usd
CY2023Q1	us-gaap	Trading Gains Losses TradingGainsLosses	3800000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	496733000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	498763000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	4610000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	5013000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1828000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1832000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	490295000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	491918000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	130038000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	105973000	usd
CY2024Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	131400000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5700000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2200000	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3100000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2800000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	26000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2024Q1	gpre	Share Based Compensation Potential Tax Benefit Realizable For Anticipated Tax Deductions Exercise Of Share Based Payment Arrangements Percentage ShareBasedCompensationPotentialTaxBenefitRealizableForAnticipatedTaxDeductionsExerciseOfShareBasedPaymentArrangementsPercentage	0.240
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51412000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-51412000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-70324000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-70324000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63341000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63341000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58549000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58549000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7634000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8598000	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	990056000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-51122000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-6043000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-5305000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-738000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	166000	usd
CY2024Q1	gpre	Stock Issued During Period Value Partnership Merger StockIssuedDuringPeriodValuePartnershipMerger	-36725000	usd
CY2024Q1	gpre	Adjustments To Additional Paid In Capital Sharebased Compensation Decrease AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationDecrease	1169000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	900468000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1061066000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-66249000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5305000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-12788000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-1701000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11087000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	185000	usd
CY2023Q1	gpre	Adjustments To Additional Paid In Capital Sharebased Compensation Decrease AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationDecrease	5573000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	973037000	usd
CY2022Q3	gpre	Incentives Related Tax Credits IncentivesRelatedTaxCredits	370000000000	usd
CY2022Q3	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	1000000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7136000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6746000	usd
CY2024Q1	gpre	Variable Lease Cost Benefit VariableLeaseCostBenefit	186000	usd
CY2023Q1	gpre	Variable Lease Cost Benefit VariableLeaseCostBenefit	-131000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	7322000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	6615000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6988000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6197000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7163000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16658000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0525
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0516
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	20885000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	23609000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	16839000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	12684000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5054000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8715000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	87786000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9735000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	78051000	usd
CY2024Q1	gpre	Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount	2300000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P5Y
CY2024Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	168600000	usd
CY2024Q1	gpre	Future Commitments For Storage And Transportation Value FutureCommitmentsForStorageAndTransportationValue	19900000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001309402-24-000092-index-headers.html	Edgar Link	pending
0001309402-24-000092-index.html	Edgar Link	pending
0001309402-24-000092.txt	Edgar Link	pending
0001309402-24-000092-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit102.htm	Edgar Link	pending
exhibit103.htm	Edgar Link	pending
exhibit104.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
exhibit41.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gpre-20240331.htm	Edgar Link	pending
gpre-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
gpre-20240331_cal.xml	Edgar Link	unprocessable
gpre-20240331_def.xml	Edgar Link	unprocessable
gpre-20240331_lab.xml	Edgar Link	unprocessable
gpre-20240331_pre.xml	Edgar Link	unprocessable
gpre-20240331_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GPRE
Green Plains Inc. Stock $gpre

2024 Q2 Form 10-Q Financial Statement

#000130940224000092 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GPRE Green Plains Inc. Stock $gpre

2024 Q2 Form 10-Q Financial Statement

#000130940224000092 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GPRE
Green Plains Inc. Stock $gpre